Last updated: February 22, 2026
Sponsor: The University of Texas Health Science Center, Houston
Overall Status: Completed
Phase
N/A
Condition
Dizzy/fainting Spells
Circulation Disorders
Vascular Diseases
Treatment
Group 1: LEE
Clinical Study ID
NCT06513169
HSC-MS-22-0145
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
American Society of Anesthesiologists (ASA)3 or lower
Patients requiring general anesthesia
Exclusion
Exclusion Criteria:
Allergic reaction to drugs commonly used for general anesthesia including fentanyl,midazolam, propofol, ephedrine and phenylephrine
Pregnant women
Requiring rapid sequence induction
Prisoners
Patient refusal
Emergency Surgery
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Group 1: LEE
Phase:
Study Start date:
August 12, 2024
Estimated Completion Date:
June 27, 2025
Connect with a study center
The University of Texas Health Science Center at Houston
Houston, Texas 77030
United StatesSite Not Available
The University of Texas Health Science Center at Houston
Houston 4699066, Texas 4736286 77030
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.